Skip to main content
CRVS logo

CRVS

Corvus Pharmaceuticals, Inc.
$15.63 +0.46 (+3.03%) At close · Jul 7
Market Cap
$1.31B
Shares
84,090,424

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 165
Total Value: $1,039,184,854
Total Shares: 71,031,083
Showing 1–100 of 173 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 164 13F filers
Top Holder
10.1%
Jun 2023 → Mar 2026 · range 10.1% – 38.7%
of institutional value
Top 5
32.9%
Jun 2023 → Mar 2026 · range 32.9% – 86.7%
of institutional value
Top 10
51.3%
Jun 2023 → Mar 2026 · range 51.3% – 95.2%
of institutional value
HHI
386
Jun 2023 → Mar 2026 · range 386 – 2,109
Broadly held
Showing 100 of 173
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 3 filings 3 filers Visit website Investor relations